BIO Annual FCF
$218.26 M
+$137.97 M+171.84%
31 December 2023
Summary:
As of January 21, 2025, BIO annual free cash flow is $218.26 million, with the most recent change of +$137.97 million (+171.84%) on December 31, 2023. During the last 3 years, it has fallen by -$258.14 million (-54.19%). BIO annual FCF is now -59.26% below its all-time high of $535.72 million, reached on December 31, 2021.BIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Quarterly FCF
$99.97 M
+$44.61 M+80.57%
30 September 2024
Summary:
As of January 21, 2025, BIO quarterly free cash flow is $99.97 million, with the most recent change of +$44.61 million (+80.57%) on September 30, 2024. Over the past year, it has increased by +$46.33 million (+86.37%). BIO quarterly FCF is now -59.30% below its all-time high of $245.60 million, reached on December 31, 2020.BIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO TTM FCF
$223.75 M
+$46.33 M+26.11%
30 September 2024
Summary:
As of January 21, 2025, BIO TTM free cash flow is $223.75 million, with the most recent change of +$46.33 million (+26.11%) on September 30, 2024. Over the past year, it has increased by +$806.00 thousand (+0.36%). BIO TTM FCF is now -66.44% below its all-time high of $666.63 million, reached on September 30, 2021.BIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.8% | +86.4% | +0.4% |
| 3 y3 years | -54.2% | -48.9% | -66.4% |
| 5 y5 years | +40.2% | +45.6% | -37.7% |
BIO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -59.3% | +171.8% | -12.8% | +704.1% | -58.2% | +178.7% |
| 5 y | 5-year | -59.3% | +171.8% | -59.3% | +704.1% | -66.4% | +178.7% |
| alltime | all time | -59.3% | +217.9% | -59.3% | +153.2% | -66.4% | +214.1% |
Bio-Rad Laboratories Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $99.97 M(+80.6%) | $223.75 M(+26.1%) |
| June 2024 | - | $55.37 M(+86.9%) | $177.42 M(-4.3%) |
| Mar 2024 | - | $29.62 M(-23.7%) | $185.49 M(-15.0%) |
| Dec 2023 | $218.26 M(+171.8%) | $38.80 M(-27.7%) | $218.26 M(-2.1%) |
| Sept 2023 | - | $53.64 M(-15.4%) | $222.95 M(+45.9%) |
| June 2023 | - | $63.43 M(+1.7%) | $152.76 M(+21.9%) |
| Mar 2023 | - | $62.39 M(+43.5%) | $125.27 M(+56.0%) |
| Dec 2022 | $80.29 M(-85.0%) | $43.49 M(-362.8%) | $80.29 M(-47.0%) |
| Sept 2022 | - | -$16.55 M(-146.0%) | $151.49 M(-58.4%) |
| June 2022 | - | $35.94 M(+106.3%) | $363.77 M(-20.8%) |
| Mar 2022 | - | $17.42 M(-84.8%) | $459.07 M(-14.3%) |
| Dec 2021 | $535.72 M(+12.4%) | $114.68 M(-41.4%) | $535.72 M(-19.6%) |
| Sept 2021 | - | $195.74 M(+49.1%) | $666.63 M(+13.6%) |
| June 2021 | - | $131.24 M(+39.5%) | $586.58 M(+10.8%) |
| Mar 2021 | - | $94.06 M(-61.7%) | $529.35 M(+11.1%) |
| Dec 2020 | $476.41 M(+32.6%) | $245.60 M(+112.3%) | $476.41 M(+29.1%) |
| Sept 2020 | - | $115.69 M(+56.3%) | $369.01 M(+14.6%) |
| June 2020 | - | $74.01 M(+80.0%) | $321.99 M(-15.5%) |
| Mar 2020 | - | $41.12 M(-70.2%) | $381.17 M(+6.1%) |
| Dec 2019 | $359.37 M(+130.9%) | $138.20 M(+101.3%) | $359.37 M(+32.0%) |
| Sept 2019 | - | $68.66 M(-48.4%) | $272.30 M(+11.7%) |
| June 2019 | - | $133.19 M(+589.6%) | $243.86 M(+50.7%) |
| Mar 2019 | - | $19.31 M(-62.2%) | $161.82 M(+4.0%) |
| Dec 2018 | $155.67 M(-1516.4%) | $51.13 M(+27.1%) | $155.67 M(+5.3%) |
| Sept 2018 | - | $40.22 M(-21.4%) | $147.82 M(+27.6%) |
| June 2018 | - | $51.15 M(+288.6%) | $115.89 M(+18.6%) |
| Mar 2018 | - | $13.16 M(-69.6%) | $97.71 M(-989.1%) |
| Dec 2017 | -$10.99 M(-114.8%) | $43.29 M(+422.1%) | -$10.99 M(+130.3%) |
| Sept 2017 | - | $8.29 M(-74.8%) | -$4.77 M(+421.5%) |
| June 2017 | - | $32.96 M(-134.5%) | -$915.00 K(-107.8%) |
| Mar 2017 | - | -$95.53 M(-293.0%) | $11.70 M(-84.3%) |
| Dec 2016 | $74.50 M(+2.3%) | $49.51 M(+307.5%) | $74.50 M(+126.1%) |
| Sept 2016 | - | $12.15 M(-73.3%) | $32.95 M(-57.9%) |
| June 2016 | - | $45.58 M(-239.2%) | $78.28 M(+100.6%) |
| Mar 2016 | - | -$32.74 M(-510.9%) | $39.03 M(-46.4%) |
| Dec 2015 | $72.84 M(-46.8%) | $7.97 M(-86.1%) | $72.84 M(+12.1%) |
| Sept 2015 | - | $57.48 M(+808.1%) | $64.96 M(-8.1%) |
| June 2015 | - | $6.33 M(+497.7%) | $70.67 M(-34.1%) |
| Mar 2015 | - | $1.06 M(+1063.7%) | $107.26 M(-21.6%) |
| Dec 2014 | $136.83 M(+121.5%) | $91.00 K(-99.9%) | $136.83 M(-23.7%) |
| Sept 2014 | - | $63.19 M(+47.2%) | $179.37 M(+19.0%) |
| June 2014 | - | $42.92 M(+40.1%) | $150.67 M(+46.3%) |
| Mar 2014 | - | $30.63 M(-28.1%) | $102.96 M(+66.7%) |
| Dec 2013 | $61.78 M(-49.3%) | $42.63 M(+23.6%) | $61.78 M(-17.4%) |
| Sept 2013 | - | $34.49 M(-819.3%) | $74.83 M(+0.4%) |
| June 2013 | - | -$4.79 M(-54.5%) | $74.52 M(-32.8%) |
| Mar 2013 | - | -$10.55 M(-118.9%) | $110.92 M(-9.0%) |
| Dec 2012 | $121.83 M(-23.6%) | $55.68 M(+62.9%) | $121.83 M(+8.8%) |
| Sept 2012 | - | $34.18 M(+8.1%) | $112.00 M(+7.7%) |
| June 2012 | - | $31.61 M(+8656.5%) | $104.00 M(-34.1%) |
| Mar 2012 | - | $361.00 K(-99.2%) | $157.90 M(-0.9%) |
| Dec 2011 | $159.41 M(+19.5%) | $45.84 M(+75.1%) | $159.41 M(-11.6%) |
| Sept 2011 | - | $26.19 M(-69.4%) | $180.40 M(-9.8%) |
| June 2011 | - | $85.51 M(+4472.8%) | $200.01 M(+52.6%) |
| Mar 2011 | - | $1.87 M(-97.2%) | $131.07 M(-1.7%) |
| Dec 2010 | $133.38 M(-46.4%) | $66.83 M(+46.0%) | $133.38 M(-17.8%) |
| Sept 2010 | - | $45.79 M(+176.3%) | $162.26 M(-17.4%) |
| June 2010 | - | $16.57 M(+296.5%) | $196.35 M(-26.0%) |
| Mar 2010 | - | $4.18 M(-95.6%) | $265.19 M(+6.6%) |
| Dec 2009 | $248.71 M(+142.5%) | $95.72 M(+19.8%) | $248.71 M(+19.2%) |
| Sept 2009 | - | $79.88 M(-6.5%) | $208.65 M(+40.0%) |
| June 2009 | - | $85.40 M(-794.6%) | $149.02 M(+32.9%) |
| Mar 2009 | - | -$12.30 M(-122.1%) | $112.16 M(+9.4%) |
| Dec 2008 | $102.56 M(-20.4%) | $55.66 M(+174.9%) | $102.56 M(-24.2%) |
| Sept 2008 | - | $20.25 M(-58.3%) | $135.40 M(-10.6%) |
| June 2008 | - | $48.55 M(-321.7%) | $151.48 M(+15.7%) |
| Mar 2008 | - | -$21.90 M(-124.7%) | $130.97 M(+1.6%) |
| Dec 2007 | $128.91 M | $88.49 M(+143.6%) | $128.91 M(+60.4%) |
| Sept 2007 | - | $36.33 M(+29.6%) | $80.37 M(-2.8%) |
| June 2007 | - | $28.04 M(-217.1%) | $82.69 M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$23.95 M(-159.9%) | $94.68 M(+45.1%) |
| Dec 2006 | $65.24 M(-9.7%) | $39.95 M(+3.4%) | $65.24 M(+0.5%) |
| Sept 2006 | - | $38.65 M(-3.5%) | $64.92 M(+33.5%) |
| June 2006 | - | $40.03 M(-175.0%) | $48.64 M(+1203.8%) |
| Mar 2006 | - | -$53.39 M(-234.7%) | $3.73 M(-94.8%) |
| Dec 2005 | $72.23 M(+15.4%) | $39.63 M(+77.2%) | $72.23 M(+11.5%) |
| Sept 2005 | - | $22.37 M(-558.2%) | $64.76 M(+19.2%) |
| June 2005 | - | -$4.88 M(-132.3%) | $54.34 M(-14.9%) |
| Mar 2005 | - | $15.11 M(-53.0%) | $63.82 M(+1.9%) |
| Dec 2004 | $62.60 M(+6.8%) | $32.16 M(+169.2%) | $62.60 M(+32.7%) |
| Sept 2004 | - | $11.95 M(+159.9%) | $47.18 M(-15.6%) |
| June 2004 | - | $4.60 M(-66.9%) | $55.90 M(-9.5%) |
| Mar 2004 | - | $13.89 M(-17.1%) | $61.79 M(+5.4%) |
| Dec 2003 | $58.64 M(-7.7%) | $16.74 M(-19.0%) | $58.64 M(-11.9%) |
| Sept 2003 | - | $20.67 M(+97.1%) | $66.53 M(+1.2%) |
| June 2003 | - | $10.48 M(-2.4%) | $65.76 M(+1.8%) |
| Mar 2003 | - | $10.74 M(-56.4%) | $64.58 M(+1.6%) |
| Dec 2002 | $63.53 M(+12.9%) | $24.64 M(+23.9%) | $63.53 M(-6.8%) |
| Sept 2002 | - | $19.90 M(+113.9%) | $68.15 M(+17.7%) |
| June 2002 | - | $9.30 M(-4.0%) | $57.91 M(-20.7%) |
| Mar 2002 | - | $9.69 M(-66.9%) | $73.02 M(+29.8%) |
| Dec 2001 | $56.27 M(-886.0%) | $29.25 M(+202.7%) | $56.27 M(+121.3%) |
| Sept 2001 | - | $9.66 M(-60.4%) | $25.43 M(+66.4%) |
| June 2001 | - | $24.41 M(-445.6%) | $15.28 M(<-9900.0%) |
| Mar 2001 | - | -$7.06 M(+346.2%) | -$82.00 K(-98.9%) |
| Dec 2000 | -$7.16 M(-96.1%) | -$1.58 M(+227.1%) | -$7.16 M(-96.3%) |
| Sept 2000 | - | -$484.00 K(-105.3%) | -$193.58 M(+0.7%) |
| June 2000 | - | $9.05 M(-164.0%) | -$192.29 M(-1.9%) |
| Mar 2000 | - | -$14.14 M(-92.5%) | -$196.04 M(+5.9%) |
| Dec 1999 | -$185.10 M(-3134.4%) | -$188.00 M(<-9900.0%) | -$185.10 M(-2568.0%) |
| Sept 1999 | - | $800.00 K(-84.9%) | $7.50 M(-16.7%) |
| June 1999 | - | $5.30 M(-265.6%) | $9.00 M(+25.0%) |
| Mar 1999 | - | -$3.20 M(-169.6%) | $7.20 M(+18.0%) |
| Dec 1998 | $6.10 M(-118.1%) | $4.60 M(+100.0%) | $6.10 M(-118.7%) |
| Sept 1998 | - | $2.30 M(-34.3%) | -$32.60 M(+1.9%) |
| June 1998 | - | $3.50 M(-181.4%) | -$32.00 M(-1.5%) |
| Mar 1998 | - | -$4.30 M(-87.4%) | -$32.50 M(-3.6%) |
| Dec 1997 | -$33.70 M(-287.2%) | -$34.10 M(-1275.9%) | -$33.70 M(-942.5%) |
| Sept 1997 | - | $2.90 M(-3.3%) | $4.00 M(-366.7%) |
| June 1997 | - | $3.00 M(-154.5%) | -$1.50 M(-122.4%) |
| Mar 1997 | - | -$5.50 M(-252.8%) | $6.70 M(-62.8%) |
| Dec 1996 | $18.00 M(-30.5%) | $3.60 M(-238.5%) | $18.00 M(-30.8%) |
| Sept 1996 | - | -$2.60 M(-123.2%) | $26.00 M(-15.6%) |
| June 1996 | - | $11.20 M(+93.1%) | $30.80 M(+18.9%) |
| Mar 1996 | - | $5.80 M(-50.0%) | $25.90 M(0.0%) |
| Dec 1995 | $25.90 M(-32.7%) | $11.60 M(+427.3%) | $25.90 M(+16.7%) |
| Sept 1995 | - | $2.20 M(-65.1%) | $22.20 M(-11.2%) |
| June 1995 | - | $6.30 M(+8.6%) | $25.00 M(-19.4%) |
| Mar 1995 | - | $5.80 M(-26.6%) | $31.00 M(-19.5%) |
| Dec 1994 | $38.50 M(+381.3%) | $7.90 M(+58.0%) | $38.50 M(-20.0%) |
| Sept 1994 | - | $5.00 M(-59.3%) | $48.10 M(+5.9%) |
| June 1994 | - | $12.30 M(-7.5%) | $45.40 M(+63.9%) |
| Mar 1994 | - | $13.30 M(-24.0%) | $27.70 M(+246.3%) |
| Dec 1993 | $8.00 M(-148.8%) | $17.50 M(+660.9%) | $8.00 M(-132.1%) |
| Sept 1993 | - | $2.30 M(-142.6%) | -$24.90 M(+70.5%) |
| June 1993 | - | -$5.40 M(-15.6%) | -$14.60 M(-8.2%) |
| Mar 1993 | - | -$6.40 M(-58.4%) | -$15.90 M(-3.0%) |
| Dec 1992 | -$16.40 M(-39.0%) | -$15.40 M(-222.2%) | -$16.40 M(+613.0%) |
| Sept 1992 | - | $12.60 M(-288.1%) | -$2.30 M(-90.3%) |
| June 1992 | - | -$6.70 M(-2.9%) | -$23.80 M(-2.1%) |
| Mar 1992 | - | -$6.90 M(+430.8%) | -$24.30 M(-9.7%) |
| Dec 1991 | -$26.90 M(+1969.2%) | -$1.30 M(-85.4%) | -$26.90 M(-3.9%) |
| Sept 1991 | - | -$8.90 M(+23.6%) | -$28.00 M(+60.0%) |
| June 1991 | - | -$7.20 M(-24.2%) | -$17.50 M(+34.6%) |
| Mar 1991 | - | -$9.50 M(+295.8%) | -$13.00 M(+900.0%) |
| Dec 1990 | -$1.30 M(-63.9%) | -$2.40 M(-250.0%) | -$1.30 M(-218.2%) |
| Sept 1990 | - | $1.60 M(-159.3%) | $1.10 M(-320.0%) |
| June 1990 | - | -$2.70 M(-222.7%) | -$500.00 K(-122.7%) |
| Mar 1990 | - | $2.20 M | $2.20 M |
| Dec 1989 | -$3.60 M | - | - |
FAQ
- What is Bio-Rad Laboratories annual free cash flow?
- What is the all time high annual FCF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual FCF year-on-year change?
- What is Bio-Rad Laboratories quarterly free cash flow?
- What is the all time high quarterly FCF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly FCF year-on-year change?
- What is Bio-Rad Laboratories TTM free cash flow?
- What is the all time high TTM FCF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM FCF year-on-year change?
What is Bio-Rad Laboratories annual free cash flow?
The current annual FCF of BIO is $218.26 M
What is the all time high annual FCF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual free cash flow is $535.72 M
What is Bio-Rad Laboratories annual FCF year-on-year change?
Over the past year, BIO annual free cash flow has changed by +$137.97 M (+171.84%)
What is Bio-Rad Laboratories quarterly free cash flow?
The current quarterly FCF of BIO is $99.97 M
What is the all time high quarterly FCF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly free cash flow is $245.60 M
What is Bio-Rad Laboratories quarterly FCF year-on-year change?
Over the past year, BIO quarterly free cash flow has changed by +$46.33 M (+86.37%)
What is Bio-Rad Laboratories TTM free cash flow?
The current TTM FCF of BIO is $223.75 M
What is the all time high TTM FCF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM free cash flow is $666.63 M
What is Bio-Rad Laboratories TTM FCF year-on-year change?
Over the past year, BIO TTM free cash flow has changed by +$806.00 K (+0.36%)